A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nAMD) in Australia and the United Kingdom

被引：0
|
作者：
Robert L. Johnston
Hans-Joachim Carius
Adrian Skelly
Alberto Ferreira
Fran Milnes
Paul Mitchell
机构：
[1] The Royal College of Ophthalmologists’ National Ophthalmology Database,Department of Ophthalmology, Westmead Millennium Institute
[2] Gloucestershire Hospitals NHS Foundation Trust,undefined
[3] QuintilesIMS,undefined
[4] Novartis Pharma AG,undefined
[5] University of Sydney,undefined
来源：
Advances in Therapy | 2017年 / 34卷
关键词：
Anti-vascular endothelial growth factor; Neovascular age-related macular degeneration; Pro re nata regimen; Ranibizumab; Real-world data; Treat-and-extend regimen; Visual acuity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：703 / 712
页数：9
相关论文
共 50 条
  • [1] A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nAMD) in Australia and the United Kingdom
    Johnston, Robert L.
    Carius, Hans-Joachim
    Skelly, Adrian
    Ferreira, Alberto
    Milnes, Fran
    Mitchell, Paul
    [J]. ADVANCES IN THERAPY, 2017, 34 (03) : 703 - 712
  • [2] Dispensing Patterns of Ranibizumab and Aflibercept for the Treatment of Neovascular Age-Related Macular Degeneration: A Retrospective Cohort Study in Australia
    Adrian Skelly
    Hans-Joachim Carius
    Vladimir Bezlyak
    Fred K. Chen
    [J]. Advances in Therapy, 2017, 34 : 2585 - 2600
  • [3] Dispensing Patterns of Ranibizumab and Aflibercept for the Treatment of Neovascular Age-Related Macular Degeneration: A Retrospective Cohort Study in Australia
    Skelly, Adrian
    Carius, Hans-Joachim
    Bezlyak, Vladimir
    Chen, Fred K.
    [J]. ADVANCES IN THERAPY, 2017, 34 (12) : 2585 - 2600
  • [4] OUTCOMES OF PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) IN GREECE UNDER RANIBIZUMAB
    Yfantopoulos, J.
    Rouvas, A.
    Chatzaras, A.
    Xanthopoulou, P.
    Theodosiadis, P.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A604 - A604
  • [5] Ranibizumab for neovascular age-related macular degeneration
    Rosenfeld, Philip J.
    Brown, David M.
    Heier, Jeffrey S.
    Boyer, David S.
    Kaiser, Peter K.
    Chung, Carol Y.
    Kim, Robert Y.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14): : 1419 - 1431
  • [6] Ranibizumab for neovascular age-related macular degeneration
    Hernandez-Pastor, Luis Javier
    Ortega, Ana
    Garcia-Layana, Alfredo
    Giraldez, Joaquin
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (19) : 1805 - 1814
  • [7] Ranibizumab for neovascular age-related macular degeneration
    Gillies, Mark C.
    Wong, Tien Y.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (07): : 748 - 749
  • [8] Ranibizumab in neovascular age-related macular degeneration
    Eng, Kenneth T.
    Kertes, Peter J.
    [J]. CLINICAL INTERVENTIONS IN AGING, 2006, 1 (04) : 451 - 466
  • [9] Treatment of neovascular age-related macular degeneration with Ranibizumab/LucentisTM
    Michels, S
    Rosenfeld, PJ
    [J]. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2005, 222 (06) : 480 - 484
  • [10] Ranibizumab for the treatment of neovascular age-related macular degeneration: A review
    Kourlas, Helen
    Abrams, Paris
    [J]. CLINICAL THERAPEUTICS, 2007, 29 (09) : 1850 - 1861
12345